Abstract
Dr. Xiufeng Ye and Dr. Guangfu Chen are both co-corresponding authors.
Accordingly, please make the following two corrections to the paper:
1) Add * to the author Xiufeng Ye.
2) *Address correspondence to Dr. Chen guangfu, szchengf@email.szu.edu.cn or Dr. Xiufeng Ye, szrosexiu@ 126.com, Shenzhen Second People’s Hospital, 3002, Sungang West Road, Shenzhen 518035, China.
Current Neurovascular Research
Title:Erratum: Erythropoietin Gene Polymorphism rs551238 is Associated with a Reduced Susceptibility to Brain Injury in Preterm Infants
Volume: 17 Issue: 3
Author(s): Xiufeng Ye*Guangfu Chen*
Affiliation:
- Shenzhen Second People’s Hospital, 3002, Sungang West Road, Shenzhen 518035,China
- Shenzhen Second People’s Hospital, 3002, Sungang West Road, Shenzhen 518035,China
Abstract: Dr. Xiufeng Ye and Dr. Guangfu Chen are both co-corresponding authors.
Accordingly, please make the following two corrections to the paper:
1) Add * to the author Xiufeng Ye.
2) *Address correspondence to Dr. Chen guangfu, szchengf@email.szu.edu.cn or Dr. Xiufeng Ye, szrosexiu@ 126.com, Shenzhen Second People’s Hospital, 3002, Sungang West Road, Shenzhen 518035, China.
Export Options
About this article
Cite this article as:
Ye Xiufeng *, Chen Guangfu *, Erratum: Erythropoietin Gene Polymorphism rs551238 is Associated with a Reduced Susceptibility to Brain Injury in Preterm Infants, Current Neurovascular Research 2020; 17 (3) . https://dx.doi.org/10.2174/156720261703200929114209
DOI https://dx.doi.org/10.2174/156720261703200929114209 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Preface [Hot Topic: Current Status of Neuroprotection in Traumatic Brain Injury (Executive Editors: Maria Mataro and Juan Sahuquillo)]
Current Pharmaceutical Design Biochemical Markers and Risk Factors of Alzheimers Disease
Current Alzheimer Research Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
Current Neuropharmacology Acute and Chronic Stress-Induced Disturbances of Microglial Plasticity, Phenotype and Function
Current Drug Targets One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke
Current Neuropharmacology Human Milk has Anti-Oxidant Properties to Protect Premature Infants
Current Pediatric Reviews Mitochondria-Targeted Drugs
Current Molecular Pharmacology Potential Protective Effect of Dl-3-n-butylphthalide on Chronic Cerebral Ischemia Brain Injury
CNS & Neurological Disorders - Drug Targets Phosphorothioate Oligonucleotides: Effectiveness and Toxicity
Current Drug Targets Therapy Against Reperfusion-induced Microvascular Injury
Current Pharmaceutical Design Use of Non-steroidal Anti-inflammatory Drugs in Pregnancy: Impact on the Fetus and Newborn
Current Drug Metabolism Neurogenesis in the Adult Brain: Implications for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Nutraceuticals against Neurodegeneration: A Mechanistic Insight
Current Neuropharmacology Unique Medicinal Properties of Withania somnifera: Phytochemical Constituents and Protein Component
Current Pharmaceutical Design Signal Transduction Pathways and Transcription Factors as Therapeutic Targets in Inflammatory Disease: Towards Innovative Antirheumatic Therapy
Current Pharmaceutical Design Targeting the Endocannabinod System to Limit Myocardial and Cerebral Ischemic and Reperfusion Injury
Current Pharmaceutical Biotechnology Tissue Elastography: Advances in Imaging the Mechanical Properties of Tissue
Recent Patents on Electrical Engineering Blood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative Diseases
Anti-Cancer Agents in Medicinal Chemistry Regulation of Neuronal Cell Death and Neurodegeneration by Members of the Bcl-2 Family: Therapeutic Implications
Current Drug Targets - CNS & Neurological Disorders